Therefore, the aim of this study is to analyze the TME of cSCC and BCC by tissue microarray (TMA) immunohistochemistry (IHC) for PD-1, PD-L1, CD28, and CD86 expression in the invasive front as well as in the core of both tumor entities. The gene discussed is CD28; the disease is neoplasm.